GE Healthcare, a unit of
, said Thursday it received clearance from the Food and Drug Administration for Carescape Patient Data Module, the fifth product of a group that will complete its Carescape suite.
The company said the product, which is used to monitor mobile patients, is part of a portfolio of patient-monitoring devices, communications networks and IT systems intended to structure data as clinical intelligence to help clinicians make decisions more efficiently.
PDM is the last of the suite's five products to achieve FDA clearance, according to a spokesperson for the company. The other four products are already on the market.
"The traditional approach to patient monitoring has outlived its usefulness," said David Ataide, vice president and general manager for GE Healthcare's Monitoring Solutions business. "Clinicians facing today's health care challenges need a new approach."